Pulse Biosciences, Inc.
PLSENASDAQHealthcareMedical Instruments & Supplies
As of Oct 23, 2026 close
- Market cap
- $3.67B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $12.56$58.90
- Volume (live)
- -
- Avg. volume (3M)
- 483.51K
Pulse Biosciences (PLSE) Stock Price & Financial Analysis
Pulse Biosciences Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $51.47 - $55.00 |
|---|---|
| 52-Week High | $58.90 |
| 52-Week Low | $12.56 |
| Open | $52.44 |
| Volume (last close) | 452.83K |
| Average Volume (3M) | 483.51K |
| Revenue (TTM) | 1.19M |
|---|---|
| Net Income (TTM) | -80.06M |
| Free Cash Flow (TTM) | -61.39M |
| EPS (TTM) | −$1.18 |
| Profit Margin | -6755.78% |
| Operating Margin | -7007.76% |
| Return on Equity (ROE) | -80.46% |
| Debt to Equity | 0.07 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 3.67B |
|---|---|
| Shares Outstanding | 69.20M |
| Price to Sales (P/S) | 3096.19 |
| Price to Book (P/B) | 36.87 |
| EV/EBITDA | -44.26 |
| 50-Day MA | $49.89 |
|---|---|
| 200-Day MA | $29.81 |
| 1-Year Change | +202.85% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Pulse Biosciences at a Glance
As of the Oct 23, 2026 close, Pulse Biosciences (PLSE) has a market capitalization of $3.67B. The stock trades at 3096.2× sales. Over the trailing twelve months it lost $80.06M on revenue of $1.19M and burned $61.39M of free cash flow.
As of its latest reported balance sheet, it holds $101.62M in cash and securities against $6.77M of debt, a net cash position of $94.85M.
Pulse Biosciences does not currently pay a dividend.
The share price is up 202.8% over the past year. At $53.02 (the Oct 23, 2026 close) it sits near the top of its 52-week range of $12.56 to $58.90, above its 200-day moving average of $29.81.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $62.33, 17.6% above the Oct 23, 2026 close.
Frequently Asked Questions About Pulse Biosciences
What is the current stock price for PLSE?
As of the Oct 23, 2026 close, PLSE stock trades at $53.02. The 52-week range is $12.56–$58.90, with a day range of $51.47–$55.00.
What is the P/E ratio for PLSE?
The P/E ratio (Price-to-Earnings) for PLSE is shown in the Key Statistics section. This valuation metric helps compare Pulse Biosciences, Inc. to industry peers.
Does PLSE pay dividends?
Pulse Biosciences does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PLSE?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for PLSE is Buy. The average 12-month price target is $62.33, a 17.6% upside from the Oct 23, 2026 close of $53.02.
What is the market cap of PLSE?
As of the Oct 23, 2026 close, Pulse Biosciences's market capitalization is $3.67B, classifying it as a mid-cap company. Pulse Biosciences operates in the Healthcare sector within the Medical Instruments & Supplies industry.